Effect of siponimod on cognitive processing speed in spms patients with active and non-active disease

被引：0
|
作者：
Penner, I. -K. [1 ,2 ]
Giovannoni, G. [3 ]
Cree, B. A. C. [4 ]
Fox, R. [5 ]
Bar-Or, A. [6 ,7 ]
Gold, R. [8 ]
Vermersch, P. [9 ]
Hach, T. [10 ]
Goeril, K. [10 ]
Ritter, S. [11 ]
Rouyrre, N. [10 ]
Piani-Meier, D. [10 ]
Benedict, R. [12 ]
机构：
[1] Heinrich Heine Univ, Dept Neurol, Med Fac, Dusseldorf, Germany
[2] COGITO Ctr Appl Neurocognit & Neuropsychol Res, Dusseldorf, Germany
[3] Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst, London, England
[4] Univ Calif San Francisco, Dept Neurol, UCSF Weill Inst Neurosci, San Francisco, CA USA
[5] Neurol Inst, Ctr Treatment & Res Multiple Sclerosis, Cleveland, OH USA
[6] Univ Penn, Ctr Neuroinflammat & Expt Therapeut, Perelman Sch Med, Philadelphia, PA 19104 USA
[7] Univ Penn, Dept Neurol, Perelman Sch Med, Philadelphia, PA 19104 USA
[8] Ruhr Univ Bochum, St Josef Hosp, Dept Neurol, Bochum, Germany
[9] Univ Lille, CHU Lille, FHU Imminent, Inserm,U1172, Lille, France
[10] Novartis Pharma AG, Basel, Switzerland
[11] Novartis Pharmaceut, E Hanover, NJ USA
[12] SUNY Buffalo, Dept Neurol, Buffalo, NY USA
来源：
MULTIPLE SCLEROSIS JOURNAL | 2020年 / 26卷 / 3_SUPPL期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P0806
引用
收藏
页码：502 / 502
页数：1
相关论文
共 50 条
  • [1] A Functional Composite Endpoint to Characterize Disease Progression in Patients with Active or Non-active SPMS
    Kappos, L.
    Cree, B.
    Bar-Or, A.
    Gold, R.
    Vermersch, P.
    Fox, R.
    Benedict, R.
    Arnould, S.
    Karlsson, G.
    Meier, D. Piani
    Dahlke, F.
    Hach, T.
    Giovannoni, G.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2021, 28 : 174 - 175
  • [2] Siponimod Slows Physical Disability Progression and Decline in Cognitive Processing Speed in SPMS Patients with Active Disease: A Post Hoc Analysis of the EXPAND Study
    Gold, R.
    Kappos, L.
    Benedict, R. H. B.
    Bar-or, A.
    Vermersch, P.
    Giovannoni, G.
    Fox, R. J.
    Hach, T.
    Ritter, S.
    Rouyrre, N.
    Karlsson, G.
    Cree, B. A. C.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 328 - 329
  • [3] Analyses Of The Effect Of Disease Duration On The Efficacy And Safety Of Siponimod In Patients With Active SPMS From The Expand Study
    Bar-Or, A.
    Cohan, S. L.
    Coyle, P. K.
    Lublin, F. D.
    Meng, X.
    Su, W.
    Cree, B. A.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (1_SUPPL) : 29 - 30
  • [4] Healthcare professionals (HCPS) categorisation of active and non-active secondary progressive multiple sclerosis (SPMS) patients
    White, J.
    Teoh, S.
    Gabriele, S.
    Vindici, J.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 243 - 244
  • [5] Siponimod improves cognitive processing speed in patients with SPMS: Results from Phase 3 EXPAND Study
    Benedict, R. H.
    Cree, B.
    Tomic, D.
    Fox, R.
    Giovannoni, G.
    Bar-or, A.
    Gold, R.
    Vermersch, P.
    Pohlmann, H.
    Karlsson, G.
    Dahlke, F.
    Kappos, L.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2018, 25 : 432 - 432
  • [6] Analyses of the Effect of Disease Duration on the Efficacy and Safety of Siponimod in Patients with Active SPMS from the Phase 3 EXPAND Study
    Cohan, Stanley L.
    Bar-Or, Amit
    Coyle, Patricia K.
    Lublin, Fred D.
    Meng, Xiangyi
    Su, Wendy
    Cree, Bruce A. C.
    [J]. NEUROLOGY, 2021, 96 (15)
  • [7] Analyses Of The Effect Of Baseline Age On The Efficacy And Safety Of Siponimod In Patients With Active SPMS From The Expand Study
    Hua, L.
    Bar-Or, A.
    Lublin, F. D.
    Meng, X.
    Su, W.
    Cree, A.
    Fox, R.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (1_SUPPL) : 29 - 29
  • [8] Analyses of the Effect of Baseline Age on the Efficacy and Safety of Siponimod in Patients with Active SPMS from the Phase 3 EXPAND Study
    Hua, Le H.
    Bar-Or, Amit
    Lublin, Fred
    Meng, Xiangyi
    Su, Wendy
    Cree, Bruce A. C.
    Fox, Robert J.
    [J]. NEUROLOGY, 2021, 96 (15)
  • [9] Identification of deregulated miRNAs in active and non-active multiple sclerosis patients
    Sorosina, Melissa
    Santoro, Silvia
    Pignolet, Beatrice
    Misra, Kaalindi
    Giordano, Antonino
    Mascia, Elisabetta
    Clarelli, Ferdinando
    Cannizzaro, Miryam
    Ferre, Laura
    Mosca, Ettore
    Liblau, Roland
    Filippi, Massimo
    Esposito, Federica
    [J]. EUROPEAN JOURNAL OF HUMAN GENETICS, 2023, 31 : 302 - 302
  • [10] Analysis of miRNA profiles in active and non-active multiple sclerosis patients
    Sorosina, M.
    Santoro, S.
    Pignolet, B.
    Misra, K.
    Giordano, A.
    Mascia, E.
    Clarelli, F.
    Cannizzaro, M.
    Ferre, L.
    Mosca, E.
    Liblau, R.
    Filippi, M.
    Esposito, F.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2022, 29 : 644 - 644
12345